Company / SG&A per Share
Monte Rosa Therapeutics, Inc. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.48
FY2024
5-year range
$0.48 / $2.64
FY2020-FY2024
Trend
-23.7%
vs FY2023
Sector context
#170 of 210
Health Care
What the data says
Monte Rosa Therapeutics, Inc.'s sg&a per share of $0.48 is lower than 81% of companies in the Health Care sector (FY2024). Improved from $0.58 to $0.48 over the past 2 years.
Based on SEC 10-K filings.
0.48 in FY2024 with a 3-year CAGR of -8.9%.
Improved from $0.58 to $0.48 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -8.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 210This company $0.48 Sector average $40.75
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share decreased 23.7% year-over-year.
- Ranks #170 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.48 | -23.7% |
| FY2023 | $0.62 | +7.7% |
| FY2022 | $0.58 | -8.0% |
| FY2021 | $0.63 | -76.2% |
| FY2020 | $2.64 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026